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A Bacillus subtilis mutant with a deletion in the citC gene, encoding isocitrate dehydrogenase, the third
enzyme of the tricarboxylic acid branch of the Krebs cycle, exhibited reduced growth yield in broth medium and
had greatly reduced ability to sporulate compared to the wild type due to a block at stage I, i.e., a failure to form
the polar division septum. In early stationary phase, mutant cells accumulated intracellular and extracellular
concentrations of citrate and isocitrate that were at least 15-fold higher than in wild-type cells. The growth and
sporulation defects of the mutant could be partially bypassed by deletion of the major citrate synthase gene
(citZ), by raising the pH of the medium, or by supplementation of the medium with certain divalent cations,
suggesting that abnormal accumulation of citrate affects survival of stationary-phase cells and sporulation by
lowering extracellular pH and chelating metal ions. While these genetic and environmental alterations were not
sufﬁcient to allow the majority of the mutant cell population to pass the stage I block (lack of asymmetric
septum formation), introduction of the sof-1 mutant form of the Spo0A transcription factor, when coupled with
a reduction in citrate synthesis, restored sporulation gene expression and spore formation nearly to wild-type
levels. Thus, the primary factor inhibiting sporulation in a citC mutant is abnormally high accumulation of
citrate, but relief of this metabolic defect is not by itself sufﬁcient to restore competence for sporulation.
Nutritional limitation leads Bacillus subtilis cells to cease
normal cell division and initiate a highly organized develop-
mental program, culminating in production of a dormant, en-
vironmentally resistant spore (11, 39). During the initiation of
sporulation, cells undergo a modiﬁed cell division (asymmetric
septation) in which a septum forms near one of the cell poles,
creating a small forespore compartment and a larger mother
cell compartment. This compartmentalization of sporulating
cells restricts the activities of sporulation-speciﬁc sigma fac-
tors, causing each compartment to have a different program of
gene expression (48). The ordered sequence of sporulation
events is strictly governed by regulatory networks which coor-
dinate nutritional, transcriptional, and morphological signals
(47, 48). One aspect of physiological control of these networks
is the metabolic and signalling role of the Krebs citric acid
cycle. A strong linkage between Krebs cycle function and
sporulation is reﬂected by the fact that Krebs cycle enzymes
are maximally induced just before the onset of sporulation and
by the ﬁnding that the absence of these enzymatic activities
causes sporulation deﬁciency (8, 15, 18, 22, 24, 27, 28, 43, 53).
Induction of the Krebs cycle at the end of the exponential
growth phase presumably allows stationary-phase cells to fully
metabolize by-products of glycolysis, such as pyruvate, lactate,
acetate, and acetoin, yielding energy, reducing power, and bio-
synthetic intermediates for the synthesis of the RNA, protein,
peptidoglycan, and lipid needed to form a spore (19).
As part of an assessment of the roles of individual citric acid
cycle enzymes in sporulation, we have determined that a mu-
tant defective in isocitrate dehydrogenase (ICDH) (the prod-
uct of citC [24]), the third enzyme of the Krebs cycle, initiates
sporulation but becomes blocked at stage I (28). That is, sporu-
lating cells of the mutant assemble a ring of the cell division
protein FtsZ at the sites at which polar septation would nor-
mally occur, but the septum does not form (28). This morpho-
logical block is reﬂected in a complementary block in gene
expression. Sporulation-speciﬁc genes expressed before septa-
tion are transcribed normally in a citC mutant, but those genes
that depend on the septation-dependent, forespore-speciﬁc,
s
F-containing form of RNA polymerase (e.g., spoIIQ [33]) are
not (28). The progression from polar localization of the FtsZ
ring to formation of the asymmetric septum is mediated in part
by an unknown gene whose expression is dependent on the
earliest functioning sporulation sigma factor, s
H (32). Since s
H
is active in a citC mutant (28), the mechanism by which the
absence of ICDH activity interferes with asymmetric septation
is not known. As shown in the accompanying paper (36), fur-
ther analysis of the stage I block in a citC mutant has revealed
that inactivation of the spoVG gene (42, 44, 46) allows the
mutant cells to overcome in part their defect in asymmetric
septation and activate forespore-speciﬁc, s
F-dependent genes.
SpoVG, which is induced at the onset of stationary phase (54),
acts as a transient negative regulator of the pathway leading to
asymmetric septum formation (36).
Other recent studies on the sporulation deﬁciency of Krebs
cycle mutants (8, 23, 24) have indicated that these mutants
have blockages at multiple steps in the sporulation pathway.
Surprisingly, a citrate synthase mutant is blocked at stage III
(23), while an aconitase mutant is blocked at stage 0 (8). Since
the absence of any of the ﬁrst three enzymes of the Krebs cycle
should cause equivalent defects in production of ATP, reduc-
ing power, and biosynthetic intermediates, these consequences
of enzyme deﬁciency cannot explain the different phenotypes
of the various mutants. To couple the developmental block in
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3382a citC mutant with the speciﬁc metabolic and physiological
changes caused by the absence of ICDH activity, we sought to
identify environmental conditions and compensatory muta-
tions that would restore sporulation competence. The results
suggest that accumulation of citrate is a major contributor to
the mutant phenotype. Moreover, we have found that the in-
hibitory effects of overabundant citrate on asymmetric septa-
tion and activation of the compartment-speciﬁc sigma factors
are mainly due to lowering of extracellular pH and depletion of
manganese.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Strains of B. subtilis used in this work
are listed in Table 1. Use of DS medium for growth and sporulation of B. subtilis
has been described elsewhere (24). Growth was monitored by measuring the
absorbance (or optical density) at 600 nm. To quantitate spore formation, 1-ml
culture samples were heated to 80°C for 10 min, diluted in sterile water, and
assayed for colony formation on DS plates. Escherichia coli JM107 (51) was used
for propagation of plasmids.
To verify the presence of the sof-1 allele of spo0A in various strains, DNA from
the strain in question was used to transform strain AG1431 (spo0F spo0B),
selecting for a chloramphenicol resistance (Cam
r) marker closely linked to
spo0A. In transformants produced by DNA from sof-1 mutants, about 50% of the
Cam
r transformants have a Spo
1 phenotype on DS plates.
Enzymatic assays of citrate and isocitrate. Cultures (30 ml) of wild-type or
mutant cells were grown in DS medium, harvested 1 h after the entry into
stationary phase (T1), and separated by centrifugation into supernatant ﬂuid and
cell pellet fractions. The supernatant ﬂuid was neutralized by addition of KOH.
The cell pellet was washed with 20 mM Tris-HCl buffer (pH 8) containing 1 mM
EDTA and then subjected to deproteinization as follows. Cells were resuspended
in 4 ml of 0.3 M perchloric acid, kept on ice for 10 min, and centrifuged. A 2-ml
sample of the resulting supernatant ﬂuid was mixed with 1 ml of 0.75 M potas-
sium carbonate and kept on ice for 15 min. After the mixture was centrifuged, the
resulting supernatant ﬂuid was used as a cell extract for enzymatic assays.
Citrate was measured by using a citric acid assay kit (Boehringer Mannheim)
as described previously (8). For measurement of isocitrate, a 50-ml sample was
added to 950 ml of ICDH assay buffer (50 mM Tris-HCl [pH 7.5], 1 mM MnCl2,
1 mM NADP
1). After puriﬁed B. subtilis ICDH (0.014 unit) (35) was added to
the reaction mixture, NADPH production, coupled to conversion of isocitrate to
2-ketoglutarate, was monitored at 340 nm. The concentration of isocitrate was
calculated from a standard curve based on commercially prepared isocitrate. One
unit of enzymatic activity was deﬁned as the amount of enzyme that produces 1
mmol of NADPH per min with a saturating concentration (0.2 mM) of DL-
isocitrate.
Measurements of intracellular metabolite pools by HPLC analysis. For each
time point, a 5-ml sample of a culture in DS medium was removed and the cells
were collected rapidly by ﬁltration through a Millipore HA ﬁlter (pore size, 0.45
mm) that had previously been boiled for 10 min in 1 liter of water to remove
contaminants. The ﬁlter was washed with ice-cold ultrapure water and plunged
into 5 ml of boiling ultrapure water. When the volume was reduced to about 0.5
ml, the liquid was cooled, transferred to a microcentrifuge tube, and stored at
280°C. For analysis, each sample was thawed, centrifuged to remove debris, and
passed through a 0.22-mm-pore-size high-performance liquid chromatography
(HPLC) ﬁlter. The HPLC analyses (4) were performed on a Dionex DX-500-
Microbore system equipped with the Pulsed Electrochemical Detector (ED40),
which was operated in conductivity mode with an Anion Self-Regenerating
Suppressor (ASRS-1) and the variable wavelength detector (AD20) set at 260
nm. The Dionex IonPac AS11 column (2 by 250 mm), equipped with a guard
column, was employed with the following sodium hydroxide gradient elution
proﬁle. The column was ﬁrst equilibrated for 10 min with 2 mM NaOH. Follow-
ing sample injection, the NaOH gradient was increased linearly from 2 to 14 mM
from 11 to 20 min, then increased with a slightly concave curve from 14 to 28 mM
NaOH from 20 to 28 min, increased linearly from 28 to 80 mM NaOH from 28
to 35 min, and ﬁnally was held at 80 mM NaOH from 35 to 40 min. The ﬂow rate
was set at 0.5 ml/min, and a 10-ml sample injection loop was used. Data were
analyzed by using PeakNet, release 4.11A, chromatography software program
TABLE 1. B. subtilis strains used in this study
Strain Genotype Source, reference,
or construction
JH642 trpC2 pheA1 J. A. Hoch
AG918 sof-1 cat trpC2 pheA1 A. D. Grossman
AG1431 spo0F DS spo0BDPstI trpC2 A. D. Grossman
MO1657 DamyE::[F(sspE9-lacZ) cat] trpC2 pheA1 17
MO2051 DamyE::[F(spoIIQ9-lacZ) cat] trpC2 pheA1 33
SC432 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] S. Cutting
SJB219 DcitC::spc trpC2 pheA1 28
SJB225 F(spoIID9-lacZ) cat trpC2 pheA1 28
SJB229 F(spoIID9-lacZ) cat DcitC::spc trpC2 pheA1 28
SJB231 DcitZC::spc trpC2 pheA1 pCS663JH642
a
SJB256 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] trpC2 pheA1 27
SJB294 DamyE::[F(spoIIQ9-lacZ) cat] trpC2 pheA1 28
SJB295 DamyE::[F(spoIIQ9-lacZ) cat] DcitC::spc trpC2 pheA1 28
SJB2192 DcitC::spc trpC2 pheA1 sof-1 cat AG918 DNA3SJB219
SR10 F(spoIID9-lacZ) cat 41
AS1 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] DcitC::spc sof-1 cat trpC2 pheA1 SJB219 DNA3KMB424
KMB119 DamyE::[F(spoIIQ9-lacZ) cat] DcitZC::spc trpC2 pheA1 MO2051 DNA3SJB231
KMB154 DamyE::[(Pspac-icdSm
b) cat] DcitC::spc trpC2 pheA1 pKM543SJB219
KMB165 DamyE::[F(sspE9-lacZ) cat] DcitC::spc trpC2 pheA1 MO1657 DNA3SJB219
KMB170 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] DcitC::spc trpC2 pheA1 SC432 DNA3SJB219
KMB174 F(spoIID9-lacZ) DcitZC::spc trpC2 pheA1 SR10 DNA3SJB231
KMB175 DamyE::[F(sspE9-lacZ) cat] DcitZC::spc trpC2 pheA1 MO1657 DNA3SJB231
KMB176 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] DcitZC::spc trpC2 pheA1 SC4323SJB231
KMB252 citC::pKM112 trpC2 pheA1 pKM1123JH642
KMB415 sof-1 cat trpC2 pheA1 AG918 DNA3JH642
KMB416 spo0A
1 cat trpC2 pheA1 cat AG918 DNA3JH642
KMB424 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] sof-1 cat trpC2 pheA1 SC432 DNA3KMB415
KMB425 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] spo0A
1 cat trpC2 pheA1 SC432 DNA3KMB416
KMB429 DcitZC::spc sof-1 cat trpC2 pheA1 SJB231 DNA3KMB415
KMB430 DcitZC::spc spo0A
1 cat trpC2 pheA1 SJB231 DNA3KMB416
KMB435 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] DcitZC::spc sof-1 cat trpC2 pheA1 SC432 DNA3KMB429
KMB436 SPbc2 D2::Tn917::pSK10D6::[F(cotA9-lacZ) cat] DcitZC::spc spo0 A
1 cat trpC2 pheA1 SC432 DNA3KMB430
a Plasmid pCS66 was introduced into strain JH642.
b The icdSm gene encodes S. mutans ICDH.
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chromatography standards and analyzed.
To calculate intracellular metabolite concentrations, a standard curve that
relates cell number to optical density at 600 nm (OD600) was prepared and an
internal volume of 1.1 3 10
29 ml per cell was assumed (50).
Deletion-insertion mutation of citZC. Plasmid pCS66 (23) contains the ﬁrst 30
amino acids of the citZ gene and the last 130 amino acids of the citC gene, with
the spectinomycin cassette (spc) inserted in-between. The orientation of the spc
gene in pCS66 is such that transcription is in the same direction as that of the citZ
and citC genes. S. Jin introduced linearized pCS66 by transformation into B.
subtilis JH642 to create strain SJB231. Transformants that were spectinomycin
resistant and chloramphenicol sensitive were shown by Southern blot analysis to
have undergone double-crossover recombination.
Expression of the Streptococcus mutants icd gene in B. subtilis. The S. mutans
icd gene, encoding ICDH, was ampliﬁed by PCR, using plasmid pJG400 (9) as
the template and oligonucleotide primers that allowed introduction of a B.
subtilis consensus ribosome binding site (RBS) just upstream of the icd coding
sequence. The PCR product (1.2 kb) was inserted at the modiﬁed EcoRV site of
pT7Blue(R) (Novagen, Inc.) (generating pKM35), and then subcloned between
the SalI and SacI sites of pBluescript SK(2) (pSK2) (Stratagene, Inc.), to create
pKM42. To eliminate possible PCR-derived errors, we replaced the 39 end of the
PCR-ampliﬁed icd gene (a HindIII-SacI fragment of about 1.2 kb) with the
corresponding region of the original icd gene from pKM34 (see below), to create
pKM49. The SalI (blunt-ended with the Klenow enzyme)-SacI fragment of
pKM49, which contains the S. mutans icd gene preceded by the B. subtilis RBS,
was inserted between the HindIII (blunt-ended) and SacI sites of pAF3 (16),
creating pKM54. After transformation of B. subtilis DcitC mutant cells with
pKM54 and selection for chloramphenicol resistance, we isolated clones in which
icd was integrated at the amyE locus and its expression was under the control of
the spac promoter (52).
pKM34 was constructed by ligating a 3.5-kb HindIII-EcoRI fragment (9acn
citZ icd) of pJG400 to pSK2 which had been cut with the same enzymes.
Cloning of the citC gene. Plasmid pKM3 (a pSK- derivative) has a HindIII-
EcoRI fragment (2.2 kb) of pCS60 (24), which contains the 39 end of the citC
gene (about 0.7 kb), the citH gene, and the 59 end of the phoP gene. The entire
citC gene was cloned by joining the SacII (blunt-ended)-HindIII fragment (0.7
kb) of pCS71 (24) to pKM3 which had been cut with SalI (blunt ended) and
HindIII, resulting in pKM4. Plasmid pKM11 was constructed by inserting a
1.4-kb DraI-EarI fragment, which contains the entire citC gene without its gene-
speciﬁc promoter, into the SmaI site of pBB544, a B. subtilis integrative vector
(2). The orientation of the citC gene in pKM11 was the same as that of the lacZ
gene in pBB544.
Site-directed mutagenesis. An essential serine (residue 103) in the active site
of B. subtilis ICDH (35) was changed to aspartic acid by PCR-mediated mu-
tagenesis (20) with pKM11 as the template and the following oligonucleotide
primers: primer a, 59-GACACCTGTCGGCGGCGGTATCCGTGATTTGAAC
GTAGCGCTC; primer b, 59-GAGCGCTACGTTCAAATCACGGATACCGC
CGCCGACAGGTGT; primer c, 59-GGAAACAGCTATGACCATG (vector-
derived sequence, upstream of citC); and primer d, 59-GTAAAACGACGGCC
AGT (vector-derived sequence, downstream of citC). The mutation is underlined
in the complementary mutagenic primers a and b. In brief, initial PCRs using
oligonucleotide primers a and d or b and c produced fragments with overlapping
ends. The entire citC gene containing the mutation was generated in a subse-
quent PCR using oligonucleotides primers c and d. In all PCR reactions, the
Expand High Fidelity PCR system (Boehringer Mannheim) was used. After the
ampliﬁed mutant citC gene was digested with BamHI and EcoRI, the DNA
fragment was cloned between the BamHI and EcoRI sites of pBB544 (Neo
r) (2),
creating pKM94. To remove other possible mutations before direct DNA se-
quencing, a 0.7-kb HindIII-ClaI (blunt-ended) fragment of pKM94 (39 end of
citC, downstream of the active-site mutation) was replaced with a HindIII-
EcoRV fragment of pKM11, resulting in pKM112.
Plasmid pKM69, a derivative of the amyE integration vector pAF3 (16) was
constructed as follows. The region of the PspacA(1)G-E. coli icd gene on the
chromosome of strain KMB15 (28) was ampliﬁed by PCR, cloned in the modiﬁed
EcoRV site of pT7Blue(R), and after cleavage with EcoRI and SacI, ligated to
pAF3 that had been cleaved with the same enzymes, creating pKM67. The
PCR-ampliﬁed E. coli icd gene preceded by the B. subtilis consensus RBS
(HindIII-SacI fragment) in pKM67 was replaced with the modiﬁed icd gene
(HindIII-SacI fragment) cloned in pKM12B (28), to create pKM69.
To test the function of B. subtilis ICDH(S103D), we constructed a plasmid
(pKM118) having the mutated citC gene fused to the spacA(1)G promoter (28)
in pKM69 and integrated this plasmid at the amyE locus in a DcitC mutant
(SJB219). The resulting strain was a glutamate auxotroph, indicating that the
point mutation disrupts ICDH enzymatic activity. Next, strain JH642 was trans-
formed with pKM112. After selection for Neo
r and screening for Glt
2 clones, a
single-crossover mutant (KMB252) was obtained for further study.
Protein analysis. Cells were harvested from an 80-ml culture, washed with 20
mM Tris-HCl buffer (pH 7.4) containing 1 mM citrate, 5 mM MnCl2,5m M
b-mercaptoethanol, 0.5 mM phenylmethylsulfonyl ﬂuoride, and 10% glycerol,
and resuspended in 2 ml of the same buffer. Cells were disrupted by sonication
and centrifuged to remove cell debris. The supernatant ﬂuid was used as a crude
extract in this study. Crude extract (3 mg) was subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis. Proteins were then electrotransferred
to Immobilon-P membranes (Millipore Corp.) with a Mini Trans-Blot transfer
cell (Bio-Rad Laboratories) according to the supplier’s instructions. ICDH was
detected by exposure to rabbit antibodies against B. subtilis ICDH (37) and
subsequent alkaline phosphatase staining (26).
Other methods. DNA manipulations were performed as described previously
(24, 36). Transformation of cells of E. coli and B. subtilis and b-galactosidase
assays were performed as described previously (24). Thin-section electron mi-
croscopic analysis was performed as described previously (28), with the assis-
tance of A. Brown-Cormier, Electron Microscopy Unit, Department of Anatomy
and Cellular Biology, Tufts University. All oligonucleotides used in this study
were synthesized by M. Berne, Tufts University Protein and Nucleic Acid Anal-
ysis Facility.
RESULTS
Growth and sporulation of a citC mutant. In nutrient broth
sporulation (DS) medium, strain SJB219 (DcitC::spc) grew at
about the same rate as did wild-type cells (Fig. 1) but reached
stationary phase at a lower cell density (;1 3 10
8 per ml versus
;5 3 10
8 per ml). Moreover, while wild-type cultures lost 20 to
40% of their cells to lysis in stationary phase, the citC mutant
cultures lost 60 to 90% of their cells. As a result of these
effects, the titer of viable citC mutant cells at T20 was #10% of
the wild-type titer. Of the surviving cells, only 0.1 to 1% formed
heat-resistant spores and total spore yield in the mutant was
0.01 to 0.1% of that in the isogenic wild-type strain (Table 2).
As shown previously, the speciﬁc stage of blockage of sporu-
lation in the citC mutant is stage I, that is, the step during
which the asymmetric septum forms (28). As a result, the citC
mutant does not express genes whose transcription is depen-
dent on s
F (e.g., spoIIQ) or any sporulation genes expressed
later (28). Despite the fact that the DcitC mutant does not grow
to as high a cell density as the wild type does, it is able to
initiate sporulation, as shown by the normal levels of expres-
sion of Spo0A-phosphate-dependent genes and bipolar local-
ization of FtsZ rings seen in the mutant (28).
During growth of the wild-type cells in DS medium, the pH
of the culture medium dropped transiently from 7.1 to about
6.8 and then rose during stationary phase to 8.0 to 8.5 (Fig. 1).
In the citC mutant culture, however, the pH dropped to 6.3 to
6.5 and was not reversed (Fig. 1). This result would be consis-
tent with the inability of these cells to import and oxidize acidic
FIG. 1. Growth and pH in DS medium. Strains JH642 (cit
1; triangles),
SJB219 (DcitC; squares), and SJB231 (DcitZC; circles) were grown in DS me-
dium, and samples were removed at the indicated times for measurement of
OD600 and, after removal of cells by centrifugation, for determination of the pH
of the medium. The time of onset of stationary phase is designated as T0.
3384 MATSUNO ET AL. J. BACTERIOL.metabolites of pyruvate generated and excreted during expo-
nential growth phase (17a). In DS medium, the primary carbon
and energy sources are amino acids and glycerol (17b).
Effect of a citC missense mutation. To know whether the
requirement for the citC gene during sporulation is a reﬂection
of the enzymatic activity of ICDH or some other role of the
protein, we created a mutant strain having a single amino
acid alteration (S103D) in the active-site serine (see Materials
and Methods). Immunoblotting analysis indicated that ICDH
(S103D) is stable in B. subtilis (data not shown). The mutant
strain was totally devoid of ICDH activity, formed spores at
0.01% of the frequency of the wild-type strain, and failed to
express a spoIIQ9-lacZ fusion, as is the case for the DcitC
mutant, implying that the enzymatic activity of B. subtilis ICDH
is the only function necessary for sporulation.
In previous work, we showed that the E. coli gene for ICDH
could fully compensate for the absence of the B. subtilis citC
gene with respect to growth and sporulation (28). To extend
this analysis, we expressed in a B. subtilis DcitC mutant the icd
gene from S. mutans (9). Again, the foreign gene for ICDH
was fully capable of compensating for the absence of B. subtilis
ICDH (data not shown). Taken together, these results support
the idea that it is the enzymatic activity of ICDH, rather than
some other hypothetical function of the protein, that is critical
for sporulation.
Metabolic defects in a citC mutant. In addition to producing
2-ketoglutarate, B. subtilis ICDH has the speciﬁc function of
generating NADPH, a substrate for synthesis of fatty acids and
some amino acids. To see whether this role of ICDH is impor-
tant in sporulation, we supplemented the medium with the
branched-chain, unsaturated fatty acids 13-methylmyristic acid
and 12-methyltetradecanoic acid (each at 16 mg per ml) and a
mixture of cysteine, arginine, lysine, methionine, and isoleu-
cine (each at a concentration of 50 mg per ml). No increase in
cell survival or sporulation was seen. As noted above, the S.
mutans ICDH fully compensates for the absence of B. subtilis
ICDH. Since S. mutans ICDH produces NADH rather than
NADPH (9), the NADPH-producing function of ICDH does
not appear to be essential for growth or sporulation in DS
broth.
As a component of the Krebs cycle, ICDH participates in
production of ATP and in gluconeogenesis. To assess the ex-
tent to which these roles of ICDH explain the stage I block of
a citC mutant, we ﬁrst measured ATP levels in mutant and
wild-type cells (Table 3). At T0, the time of transition from
exponential growth to stationary phase, the ATP level in both
mutant and wild-type cells was approximately 1.5 mM (Ta-
ble 3). One hour later, at T1, when the asymmetric septum
is formed, the ATP concentration was higher in mutant cells
than in wild-type cells (Table 3). Next, we added glucose to
mutant and wild-type cells to provide an alternative source of
ATP and to obviate the need for gluconeogenesis. Because
glucose is normally a potent inhibitor of sporulation, we used
a strain carrying a spo0A mutation, sof-1, that prevents inhibi-
tion of sporulation by glucose (21). Addition of glucose to
citC
1 sof-1 and DcitC sof-1 cultures allowed growth of the
DcitC mutant to a higher cell density but caused only a very
small increase in sporulation (Table 2) or spoIIQ9-lacZ expres-
sion (data not shown) by the citC mutant strain. We conclude
that the block at stage I seen in citC mutant cells is not solely
caused by a deﬁciency in ATP or gluconeogenesis or both.
TABLE 2. Sporulation of tricarboxylic acid cycle mutants
Addition to
medium
a Genotype Maximum
OD600
b
Maximum
titer
c
Titer at
T20
d
Spore titer
at T20
d
Sporulation
efﬁciency
e
Sporulated
fraction
f
Relative sporulation
frequency
g
None cit
1 1.9 8.5 3 10
8 4.7 3 10
8 4.6 3 10
8 0.54 0.98 (1.0)
DcitC 1.2 1.4 3 10
8 1.4 3 10
7 5.7 3 10
4 0.0004 0.004 0.0001
DcitZC 1.5 4.7 3 10
8 7.7 3 10
7 1.3 3 10
7 0.028 0.17 0.03
DcitZC sof-1 1.5 1.4 3 10
8 1.1 3 10
8 0.78 0.24
MnCl2 cit
1 2.0 3.5 3 10
8 3.3 3 10
8 3.0 3 10
8 0.85 0.91 (1.0)
DcitC 1.1 1.6 3 10
8 5.3 3 10
7 1.5 3 10
6 0.009 0.028 0.005
HEPES cit
1 1.6 5.8 3 10
8 6.9 3 10
8 6.4 3 10
8 1.10 0.93 (1.0)
DcitC 1.1 3.1 3 10
8 4.4 3 10
7 3.3 3 10
6 0.001 0.075 0.005
Glt cit
1 2.3 5.4 3 10
8 5.2 3 10
8 0.96 (1.0)
DcitC 1.6 7.7 3 10
7 7.2 3 10
6 0.09 0.012
Glucose citC
1 sof-1 2.1 7.2 3 10
8 8.2 3 10
8 8.2 3 10
8 1.13 1.00 (1.0)
DcitC sof-1 2.2 2.1 3 10
8 7.0 3 10
6 1.2 3 10
5 0.006 0.017 0.0001
a Final concentrations of additions to DS medium were as follows: 0.75 mM MnCl2, 50 mM HEPES (pH 8), 0.2% glutamate (Glt), and 0.1% glucose.
b Maximum OD600 was deﬁned as the highest OD600 in early stationary phase.
c Maximum titer was the concentration of viable cells at the highest cell density.
d At T20, viable-cell titer was determined and samples of cultures were heated at 80°C for 10 min to test for heat-resistant spore formation.
e Sporulation efﬁciency is deﬁned as the ratio of heat-resistant CFU at T20 to maximum titer in early stationary phase.
f Sporulated fraction is deﬁned as the ratio of heat-resistant CFU to total viable cell titer at T20.
g Relative sporulation frequency is deﬁned as heat-resistant spore titer in cit mutant cultures relative to that in cit
1 cultures.
TABLE 3. Metabolite pools in DcitC mutant and wild-type
cells determined by HPLC analysis
a
Strain (relevant
genotype) Time
AMP
concn
(mM)
ADP
concn
(mM)
ATP
concn
(mM)
Phosphoenol-
pyruvate concn
(mM)
JH642 (cit
1) T0 4.8 4.9 1.5 0.94
T1 3.1 3.5 3.0 1.3
SJB219 (DcitC) T0 7.9 1.5 1.5 1.5
T1 4.8 6.3 3.9 2.3
a HPLC analysis of metabolite pools was performed as described in Materials
and Methods.
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way can be predicted to cause not only a deﬁciency in the
products of the pathway but also accumulation to abnormal
levels of one or more intermediates upstream of the inter-
rupted step. We therefore examined the concentrations of
citrate and isocitrate in citC mutant cells. The measurement
of these metabolites by enzymatic assays (see Materials and
Methods) showed that the culture medium of the citC mutant
cells at T1 contained both citrate and isocitrate at 10- to 15-
fold-higher levels than those found in the wild-type culture
medium (Table 4). The intracellular concentration of citrate
was also 10-fold higher in the citC mutant than in a wild-type
extract, but the intracellular concentration of isocitrate was too
low to be measured accurately by this assay (Table 4). There-
fore, we conducted a more-detailed analysis of intracellular
metabolites by HPLC (see Materials and Methods). The
HPLC analysis indicated that the citC mutant had 15- to 20-
fold-higher intracellular concentrations of citrate and isocit-
rate than did wild-type cells (Table 4). This result ﬁts with the
absence of ICDH activity and the fact that the equilibrium of
aconitase greatly favors conversion of isocitrate to citrate. It is
noteworthy that all other pools examined by HPLC, including
ATP, ADP, AMP, and phosphoenolpyruvate were at least as
high in the citC mutant as in wild-type cells (Table 3). We do
not know whether variations in the ratios of the nucleotides in
any given extract are signiﬁcant.
Phenotype of a citZ citC mutant. To see whether the exces-
sive accumulation of citrate and isocitrate is responsible for the
lower growth yield and sporulation deﬁciency of the citC mu-
tant, we constructed a mutant strain from which the major
citrate synthase gene (citZ) and the citC gene were deleted
simultaneously. Concentrations of citrate and isocitrate in the
culture medium were reduced to near-wild-type levels (Table
4). Note that this strain continues to produce citrate at a low
rate due to the activity of the citA gene product, a second
isozyme of citrate synthase (24), but fails to convert citrate or
isocitrate to 2-ketoglutarate because of the citC mutation. This
DcitZC strain (SJB231) grew to a higher cell density than did
the citC mutant and survived better in stationary phase (ﬁnal
titer of 7.7 3 10
7 per ml [Table 2]), supporting the idea that
accumulation of citrate is in some way harmful to cell survival
in stationary phase. One of the consequences of accumulation
of citrate might be to lower the pH of the culture medium.
In fact, the pH of the culture medium of the citZC mutant
reached about 7.5 (about 1 unit higher than that of the citC
mutant but still 1 unit lower than in the wild-type strain) in
stationary phase (Fig. 1). The double-mutant cells produced
100 times more spores per ml than did the citC mutant cells
(Table 2), but the majority of the double-mutant cells were still
blocked at stage I of the developmental pathway as determined
by measurements of spoIIQ9-lacZ expression (see below).
The ﬁnding that substantial reduction in citrate synthesis
partially suppresses the defect in growth and sporulation of a
citC mutant was conﬁrmed by the isolation of spontaneous
variants of SJB219. Colonies of SJB219 on DS plates are trans-
lucent due to substantial lysis of the cells. After several days of
incubation, less-translucent papillae arose on many of the col-
onies. One such spontaneous variant was analyzed in detail.
The mutation responsible for altered colony morphology was
approximately 90% linked to DcitC::spc by transformation,
suggesting that it was likely to lie within the citZCH operon.
The double mutant grew and formed spores at the same fre-
quency as SJB231 (DcitZC) (Table 2). Extracts of the variant
strain showed that it had the same level of malate dehydroge-
nase (CitH) activity as in SJB219 but essentially no citrate
synthase (CitZ) activity. Thus, the mechanism of suppression is
apparently a reduction in accumulation of citrate due to inac-
tivation of citZ. A mutant strain with deletions of both citrate
synthase genes (citA and citZ) and of citC had a phenotype very
similar to that of the citZC deletion strain (data not shown).
Reduction of citrate synthase activity also serves to cure in part
the growth defect of an ICDH mutant of E. coli (31).
Effects of divalent cations. Accumulation of citrate in the
citC mutant might also interfere with sporulation by chelat-
ing divalent cations and inhibiting the activity of one or more
metal ion-dependent enzymes. We therefore added excess
MnCl2, MgSO4, and FeSO4, separately or together, to DS
medium. Raising the MnCl2 concentration in the medium from
0.01 mM (the standard concentration) to 0.5 or 0.75 mM had
no signiﬁcant effect on wild-type cells but increased sporula-
tion of the citC mutant by 100- to 1,000-fold (Table 2). Higher
concentrations inhibited sporulation. Similarly, increasing the
FeSO4 concentration from 0.001 to 0.05 mM increased spore
formation by the citC mutant by 50- to 100-fold. Supplemen-
tation of MnCl2 and FeSO4 simultaneously had no additive
effect. Addition of supplementary MgSO4 did not increase
sporulation efﬁciency. Thus, sporulation of the citC mutant
seems to be limited in part by availability of certain divalent
cations, presumably because of excess citrate accumulation.
TABLE 4. Measurements of citrate and isocitrate
a
Strain
Intracellular concn by: Extracellular concn
by enzyme assay
Enzyme assay HPLC analysis
Citrate
(mM)
Isocitrate
(mM)
Citrate
(mmol/
OD600)
b
Isocitrate
(mmol/
OD600)
b
Citrate
(mM)
Isocitrate
(mM)
cit
1 ,0.073 ,0.024 1.3 0.17 0.062 ,0.02
DcitC 0.86 ,0.042 22 3.6 0.89 0.29
DcitZC 0.45 ,0.029 0.12 ,0.02
a Cells were grown to stationary phase (T1) in DS medium, and samples for
measurements of citrate and isocitrate were prepared by the methods described
in Materials and Methods.
b Total citrate or isocitrate (in micromoles) in cell extracts prepared from
30-ml cultures was normalized by dividing by the OD600 of the culture at the time
of harvesting.
TABLE 5. Expression of sporulation genes in
tricarboxylic acid cycle mutants
Relevant
genotype
Supplement to
medium
b
Relative expression of sporulation
genes (%)
a
spoIIQ spoIID sspE cotA
DcitC None ,10 ,10 ,10 ,10
HEPES ,10 ,10 ,10 ,10
MnCl2 25 22 ,10 ,10
HEPES 1 MnCl2 20 13 ,10 ,10
DcitC sof-1 None ,10 ,10
DcitZC None 26 13 ,10 ,10
DcitZC sof-1 None 110
a B. subtilis strains carrying a promoter of a sporulation gene (s
F-dependent
spoIIQ, s
E-dependent spoIID, s
G-dependent sspE,o rs
K-dependent cotA) fused
to the E. coli lacZ gene were grown in DS broth and harvested every hour after
onset of stationary phase for measurements of b-galactosidase activity. The levels
of expression of the lacZ fusions in mutants were estimated relative to the
maximum level of expression of the same fusions in the wild-type strain. The
average b-galactosidase activities (in Miller units) for the wild-type strains were
as follows: spoIIQ-lacZ, 120; spoIID-lacZ, 27; sspE-lacZ, 250; and cotA-lacZ, 100.
b In some experiments, 50 mM HEPES (pH 8) or 0.75 mM MnCl2 or both
were added to DS medium.
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expression of spoIIQ9-lacZ to the majority of the cells, it did
allow a detectable increase in expression of both spoIIQ and
spoIID (Table 5).
Effect of pH alteration. While searching for physiological
conditions that would restore spoIIQ9-lacZ expression to a citC
mutant, we unexpectedly found that addition of KOH to un-
buffered DS medium has a signiﬁcant stimulatory effect on
spoIIQ expression. As shown in Fig. 2b, when KOH was added
to the citC mutant culture to give a ﬁnal concentration of 5
mM, high-level spoIIQ expression was observed, despite the
fact that the growth rate dropped slightly over the same period.
The pH of the culture medium just after KOH addition was
almost 9 and then decreased to 8.0 to 8.5 over 4 h (Fig. 2a).
The optimum concentration of KOH was determined to be 5 to
6.25 mM (Fig. 2c); a higher concentration of KOH (for exam-
ple, 7.5 mM) caused aggregation of the cells, and no spoIIQ
expression was observed. Altering the time of addition of KOH
showed that KOH had its strongest activating effect on
spoIIQ9-lacZ expression when it was added to the mutant cul-
ture at around T0 (Fig. 2d), while such addition caused delayed
expression of spoIIQ9-lacZ in the wild-type strain (data not
shown). The restoration of spoIIQ9-lacZ expression in the
citC mutant is apparently due to raising the pH rather than
increasing availability of K
1 ions, since NaOH had the same
effect as KOH (Fig. 2b) and KCl had no stimulatory effect
(data not shown). These results suggest that raising the pH
at T0 allows the citC mutant to bypass the stage I block in
sporulation.
Under these conditions, however, the sporulation frequency
of the citC mutant was not improved. Electron microscopy
showed that about 50% of the cells were able to pass the stage
I block in sporulation and that about half of these cells reached
the engulfed forespore stage by T6 (Fig. 3). Mother cell-spe-
ciﬁc, s
E-dependent spoIID expression (41) and forespore-spe-
ciﬁc, s
G-dependent sspE expression (12) were partially acti-
FIG. 2. Effect of KOH on spoIIQ9-lacZ expression in a DcitC mutant. (a and b) Cells of strain SJB295 (DcitC) were grown in DS broth (triangles). After 5 mM KOH
(circles) or NaOH (diamonds) was added to the culture at T0, the OD600 (panel a, closed symbols), pH of the medium (panel a, open symbols) and spoIIQ9-lacZ
expression (panel b) were measured. (c) Different concentrations of KOH were added to the culture at T0 (3, no addition; h, 2.5 mM; E, 5 mM; , 6.25 mM). (d)
KOH (5 mM) was added to the culture at T21.25 ({), T20.5 (h), T0 (E), or T1 (). 3, control (no KOH added).
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K-dependent expression of the
cotA gene (45) was still at a very low level (data not shown).
To assess further the importance of extracellular pH control
in growth and sporulation of the citC mutant, we added
HEPES (50 to 100 mM) or Tris (50 to 100 mM) buffers to DS
medium to maintain a constant pH of 8.0 to 8.5. In such media,
neither growth nor survival of the citC mutant was signiﬁcantly
improved, but the fraction of surviving cells that formed spores
increased substantially (Table 2). Expression of spoIIQ9-lacZ
was not recovered, however (Table 5), even when the buffer
was added at T0 (data not shown). Simultaneous addition of
HEPES or Tris (50 mM) and excess MnCl2 (0.75 mM) had no
additive effect on heat-resistant spore formation (data not
shown) or on spoIIQ9-lacZ expression (Table 5).
Effects of supplementation of metabolites. The failure of
citC mutant cells to grow to high titer is probably due primarily
to the failure to utilize fully the by-products of pyruvate me-
tabolism (acetate, lactate, and citrate). The effect might also be
due in part to the failure to synthesize adequate 2-ketogluta-
rate. If so, addition to the medium of metabolites produced
from 2-ketoglutarate might alleviate the defect. When the citC
mutant cells were grown in DS medium supplemented with
0.2% glutamate, they grew to a higher density (as did the wild-
type cells) and, as a result, achieved a high titer in late sta-
tionary phase. Moreover, 9% of the surviving cells were heat-
resistant spores (#2% of the wild-type spore production)
(Table 2). Two types of explanations for this result can be
imagined. On the one hand, citC mutants in DS medium might
be limited for glutamate or 2-ketoglutarate. This seems very
unlikely, however, since nutrient broth, the only organic con-
stituent of DS medium, is made from boiled meat and contains
substantial quantities of most amino acids, including gluta-
mate. In fact, DS medium contains sufﬁcient glutamate to
permit normal growth and sporulation of a glutamate synthase
mutant, which is an absolute glutamate auxotroph (3). In ad-
dition, glutamate dehydrogenase activity is induced in DS me-
dium (3), allowing conversion of glutamate to 2-ketoglutarate.
On the other hand, the addition of glutamate might have
indirect effects on cell physiology. In fact, glutamate addition
caused the pH of the culture medium to rise during growth so
that even in citC mutant cells, it was .8.0 in stationary phase.
Moreover, the effect of glutamate was mimicked by and addi-
tive with supplementation with succinate or aspartate (data not
shown). Although addition of each of these compounds may
help the citC mutant to sporulate for a different reason, the
simplest interpretation is that they all work by causing extra-
cellular pH to rise.
Synergistic effects of mutations in citZ and spo0A. A mutant
strain with both citZ and citC deleted was able to pass through
stage I of sporulation and express, to a signiﬁcant extent, genes
dependent on s
F and, to a lesser extent, s
E (Fig. 4 and Table
5). The double mutant did not express genes dependent on
s
G or s
K, however (Fig. 4 and Table 5). In an attempt to ﬁnd
conditions that would allow this double-mutant strain to
progress further in the sporulation pathway, we tested the
effects of introducing additional mutations. Surprisingly, com-
plete restoration of s
K-dependent cotA9-lacZ expression and
nearly complete restoration of spore formation were seen
when the sof-1 allele of the spo0A gene was introduced into the
DcitZC strain (Fig. 4C and Tables 2 and 5). This was the only
combination of conditions or mutations that had such a strong-
ly suppressive effect on the absence of ICDH. As shown above,
the sof-1 mutation had no suppressive effect on a DcitC single
mutant strain; its ability to suppress seems dependent on a
reduction in citrate synthesis and accumulation.
DISCUSSION
Abnormal accumulation of citrate and isocitrate seems to
be responsible for the earliest sporulation defect, i.e., lack of
asymmetric septation, in a citC mutant. Citrate and isocitrate
accumulate to unusually high levels because they cannot be
further metabolized in the absence of ICDH. No citrate lyase
or isocitrate lyase or other citrate- or isocitrate-degrading ac-
tivity has been found in B. subtilis (13, 37), and examination of
the B. subtilis genome sequence (30) revealed no homolog of
E. coli citrate lyase, isocitrate lyase, or malate synthase. Such
accumulation of citrate and isocitrate apparently has two neg-
ative effects on sporulation. First, the pH of the medium re-
mains low (at 6.5) as cells enter stationary phase. By contrast,
the pH of the culture medium of wild-type cells rises in sta-
tionary phase to 8.5 due, at least in part, to uptake of previous-
ly excreted organic acids, their conversion to citrate, and their
subsequent oxidation. Asymmetric septation occurs at a time
(approximately T1) when the extracellular pH is 7.5 to 8.0. In
the citC mutant, extracellular organic acids, such as acetate and
lactate, can presumably be taken up and converted to citrate
and isocitrate, but no further metabolism ensues and citrate
and isocitrate are excreted, maintaining low environmental
pH. We have not measured the effect of the absence of ICDH
on intracellular pH. In wild-type cells, internal pH is kept al-
most constant during growth and during most of sporulation
(6, 7, 29, 34).
Raising external pH restored sporulation gene expression to
a signiﬁcant fraction of the citC mutant cells only when it was
accomplished by the addition of inorganic alkali or certain
Krebs cycle-derived compounds (glutamate, succinate, and as-
partate); organic buffers affected only a small minority of the
cell population even though they raised the extracellular pH to
8.0 or higher. We do not know either the basis for this differ-
ence or the mechanism that seems to link extracellular pH and
asymmetric septation. It is possible that efﬁcient uptake of the
pH-altering agent is critical.
FIG. 3. Thin-section electron microscopic analysis. Cells of a DcitC mutant
strain (SJB219) were grown in DS medium to the end of exponential growth
phase (T0), and 5 mM KOH was added to the culture. KOH-treated cells were
harvested 6 h after the addition of KOH, and samples were prepared for trans-
mission electron microscopy.
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has also been seen by others (6, 7). In DS medium supple-
mented with glucose and glutamine, the pH of the medium
drops to 5.5, at which point the accumulation of s
H and ex-
pression of s
H-dependent genes is inhibited. The same mech-
anism is unlikely to be responsible for the phenotype of a citC
mutant, since the pH does not reach 5.5 and expression of
s
H-dependent genes is not inhibited (28).
The second effect of excess citrate and isocitrate appears to
be chelation of Mn
21 (and perhaps Fe
21). Since the block in
asymmetric septation can be bypassed in part of the cell pop-
ulation by addition of KOH or NaOH, we suggest that low pH
is the primary deterrent to asymmetric septation in citC mutant
cells. However, Mn
21 must also contribute to asymmetric sep-
tation, since expression of septation-dependent genes in a citC
spoVG double mutant is raised signiﬁcantly by supplementa-
tion with excess Mn
21 even though the pH remains low (36).
The mechanistic basis of the cation effect is unknown. At least
ﬁve enzymes of B. subtilis, aconitase (14), fructose-1,6-diphos-
phate aldolase (14), ICDH (37, 40), phosphoglycerate phos-
phomutase (38), and SpoIIE, a phosphatase that activates s
F
by helping to liberate it from its inhibitor protein (10), are
known to be Mn
21 or Fe
21 dependent and required for early
sporulation events. SpoIIE is a particularly intriguing candi-
date for the Mn
21 target, since it localizes to the septum, is
important for septum assembly or stability (28a), and is needed
to activate s
F in the forespore (1).
Surprisingly, the roles of ICDH in ATP production, glucone-
ogenesis, and NADPH synthesis do not appear to be crucial for
asymmetric septation, at least in DS medium. No defect in
ATP synthesis was found in the citC mutant grown in DS
medium at least until T1 and addition of glucose did not permit
citC mutant cells to septate. Replacement of the B. subtilis citC
gene by an S. mutans gene that expresses an NADH-producing
ICDH completely restored sporulation to wild-type levels.
No single physiological condition or single suppressing mu-
tation was able to restore sporulation completely to the citC
mutant. Although addition of buffer, divalent cations, or cer-
tain metabolites to DS medium increased the fraction of the
citC mutant population that survived and sporulated, it did not
allow the vast majority of the population to advance beyond
the original stage of blockage in the developmental program.
Only the combination of reduction in citrate synthesis caused
by a citZ mutation and alteration of the Spo0A transcription
factor by the sof-1 mutation was able to restore late spo gene
expression to the citC mutant. These results have two implica-
tions. First, the defects caused by the absence of Krebs cycle
enzymes are manifold and affect multiple stages of sporulation.
Even when early blockages are overcome by alterations in the
environment or by a suppressing mutation, the cells are still
blocked at a late stage of sporulation. Although neither energy
nor reducing power appears to be limiting at early stages, one
or the other may eventually become limiting as mutant cells try
to complete the sporulation process. Second, the cell popula-
tion is heterogeneous in its response to the additions, an idea
consistent with a mechanism in which threshold concentrations
FIG. 4. Effects of citZ and sof-1 mutations on spo gene expression in a citC
mutant. All strains were grown in DS medium and sampled for assays of b-ga-
lactosidase activity at the indicated times after the end of exponential growth
(T0). (A) Strains SJB294 (cit
1)( n), SJB295 (DcitC)( F), and KMB119 (DcitZC)
() were tested for spoIIQ9-lacZ expression. (B) Strains SJB225 (cit
1)( n),
SJB229 (DcitC)( F), and KMB174 (DcitZC)( ) were assayed for spoIID9-lacZ
expression. (C) Strains KMB425 (cit
1)( n), KMB170 (DcitC)( F), KMB436
(DcitZC)( ), AS1 (DcitC sof-1)( E), and KMB435 (DcitZC sof-1)( ) were
assayed for cotA9-lacZ expression.
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past its genetically determined stage of blockage (5).
The mechanism of the synergistic suppression of the citC
defect by mutations in citZ and spo0A (sof-1) is unclear. Since
the sof-1 mutation by itself has no suppressive effect and since
the citZ mutation is epistatic to the citC mutation, the most
likely explanation is that an alteration in the Spo0A phos-
phorelay allows the need for CitZ to be bypassed. The pheno-
type of a citrate synthase mutant is to be blocked at morpho-
logical stage III (23), but expression of even early classes of
spo genes is delayed (49). Perhaps the sof-1 mutation, which
allows activation of Spo0A independently of the phosphore-
lay and normal developmental signals, overcomes a timing
defect caused by the citZ mutation. In combination with a
reduction in citrate synthesis and accumulation, the deleteri-
ous effects of the absence of ICDH are largely overcome.
In the accompanying paper (36), we show that loss-of-func-
tion mutations in the spoVG gene also cause a partial bypass of
the citC mutant phenotype. The suppressive effect of a spoVG
mutation is enhanced by deletion of citZ, especially in combi-
nation with a sof-1 mutation. SpoVG is suspected to affect
asymmetric septation by altering the expression or inhibiting
the activity of a Spo0A-dependent gene.
Interestingly, mutants blocked in each of the ﬁrst three steps
in the Krebs cycle have different sporulation phenotypes. A
citA citZ mutant, deﬁcient in both citrate synthases, proceeds
as far as stage III in sporulation (23, 49), while an aconitase
(citB) null mutant is blocked at stage 0 (8). The citrate synthase
mutant makes no citrate, and the pH of its medium (7.5) is
considerably higher than that of the other two mutants, con-
sistent with the idea that asymmetric septation and other early
stages of sporulation are very pH sensitive and divalent cation
dependent. In fact, the aconitase mutant may have the earliest
block because it accumulates the greatest amount of extra-
cellular citrate (8), and its extracellular pH is even lower (by
about 0.4 pH unit) than that of the ICDH mutant (37). Not
surprisingly, citrate synthase mutations are epistatic to both
aconitase and ICDH mutations (reference 8 and this work).
It was previously reported that a mutant (DcitA::neo DcitZ471
citC7) lacking the major and minor citrate synthases and ICDH
was blocked in sporulation at stage 0 (22). In the present study,
we examined a strain (DcitA::neo DcitZC::spc) lacking the same
three enzymes but created with different mutations and found
that its sporulation phenotype was different than that of the
previous strain. Cells of the newer strain were able to express
Spo0A-phosphate-, s
F- and s
E-dependent genes. We assume
that the speciﬁc mutations carried by the previous strain caused
an unusual phenotype or that the strain had acquired an
unrecognized, additional mutation that caused a block at
stage 0.
The multiple deleterious changes in cellular physiology
caused by the absence of ICDH activity provide compelling
reasons for regulating synthesis of this enzyme during sporu-
lation. The fact that the citC gene is transcribed from its own
promoter as well as from the citZCH operon promoter (25)
may allow the cell to adjust citC expression to the speciﬁc
environmental conditions in which cells ﬁnd themselves.
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